PromarkerD Predicts Renal Function Decline in Type 2 Diabetes in the Canagliflozin Cardiovascular Assessment Study (CANVAS)

PromarkerD Predicts Renal Function Decline in Type 2 Diabetes in the Canagliflozin Cardiovascular Assessment Study (CANVAS)

The ability of current tests to predict chronic kidney disease (CKD) complicating diabetes is limited. This study investigated the prognostic utility of a novel blood test, PromarkerD, for predicting future renal function decline in individuals with type 2 diabetes from the CANagliflozin CardioVascu...

Full description

Bibliographic Details
Main Authors: Kirsten E. Peters, Jialin Xu, Scott D. Bringans, Wendy A. Davis, Timothy M.E. Davis, Michael K. Hansen, Richard J. Lipscombe
Format: Article
Language:English
Published: MDPI AG 2020-10-01
Series:Journal of Clinical Medicine
Subjects:
type 2 diabetes
diabetic nephropathy
renal decline
chronic kidney disease
biomarkers
risk prediction
Online Access:https://www.mdpi.com/2077-0383/9/10/3212

Internet

https://www.mdpi.com/2077-0383/9/10/3212

Similar Items